Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results.
Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%.
GAAP net earnings rose nearly 70% YoY to $2 billion and EPS rose nearly 73% to $1.14. Adjusted EPS grew 22.2% to $1.43.
For FY2022, GAAP EPS is expected to be at least $3.50 and adjusted EPS is expected to be at least $4.90.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Disney (DIS): A look at the major winning points for its streaming business
Shares of the Walt Disney Company (NYSE: DIS) have been rallying since the entertainment leader delivered strong results for its third quarter of 2022 a day ago. The stock was
KSS Stock: After terminating sale talks, what awaits Kohl’s this year
Kohl’s Corporation (NYSE: KSS) has been on investors' radar ever since the retailer put itself up for sale earlier this year, after coming under pressure from activist investors. Putting an
Walt Disney Company (DIS) Q3 revenues, earnings beat Street view
Entertainment behemoth The Walt Disney Company (NYSE: DIS) on Wednesday reported higher revenues and earnings for the third quarter of 2022. The results also topped expectations. Third-quarter revenues of the Los
